118 related articles for article (PubMed ID: 18981691)
21. siRNA knockdown of gene expression in endothelial cells.
Dennstedt E; Bryan B
Methods Mol Biol; 2011; 764():215-22. PubMed ID: 21748643
[TBL] [Abstract][Full Text] [Related]
22. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
23. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
24. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
[TBL] [Abstract][Full Text] [Related]
25. Ago2 and GW182 expression in mouse preimplantation embryos: a link between microRNA biogenesis and GW182 protein synthesis.
Shen XH; Han YJ; Cui XS; Kim NH
Reprod Fertil Dev; 2010; 22(4):634-43. PubMed ID: 20353723
[TBL] [Abstract][Full Text] [Related]
26. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
27. Targeted cancer treatment using a combination of siRNA-liposomes and resveratrol-electrospun fibers in co-cultures.
Al-Attar T; Madihally SV
Int J Pharm; 2019 Oct; 569():118599. PubMed ID: 31394186
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
[TBL] [Abstract][Full Text] [Related]
29. Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
Asai T; Matsushita S; Kenjo E; Tsuzuku T; Yonenaga N; Koide H; Hatanaka K; Dewa T; Nango M; Maeda N; Kikuchi H; Oku N
Bioconjug Chem; 2011 Mar; 22(3):429-35. PubMed ID: 21361311
[TBL] [Abstract][Full Text] [Related]
30. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
31. [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes].
Wang W; Tang N; Zhang CL; Liu XJ; Hu H; Zhang ZX; Liang W
Yao Xue Xue Bao; 2006 Feb; 41(2):142-8. PubMed ID: 16671545
[TBL] [Abstract][Full Text] [Related]
32. Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
Kenjo E; Asai T; Yonenaga N; Ando H; Ishii T; Hatanaka K; Shimizu K; Urita Y; Dewa T; Nango M; Tsukada H; Oku N
Biol Pharm Bull; 2013; 36(2):287-91. PubMed ID: 23370357
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
Koide H; Asai T; Kato H; Yonenaga N; Yokota M; Ando H; Dewa T; Nango M; Maeda N; Oku N
Nanomedicine; 2015 Jan; 11(1):185-94. PubMed ID: 25240598
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
[TBL] [Abstract][Full Text] [Related]
35. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
[TBL] [Abstract][Full Text] [Related]
36. Knock-down of argonaute 2 (AGO2) induces apoptosis in myeloid leukaemia cells and inhibits siRNA-mediated silencing of transfected oncogenes in HEK-293 cells.
Naoghare PK; Tak YK; Kim MJ; Han E; Song JM
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):274-82. PubMed ID: 21535412
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic vessel-targeting DDS by liposomalized oligopeptides.
Asai T; Oku N
Methods Mol Biol; 2010; 605():335-47. PubMed ID: 20072892
[TBL] [Abstract][Full Text] [Related]
39. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
Şalva E; Turan SÖ; Eren F; Akbuğa J
Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.
Kim D; Ku SH; Kim H; Jeong JH; Lee M; Kwon IC; Choi D; Kim SH
J Control Release; 2016 Dec; 243():182-194. PubMed ID: 27765623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
